Olivia Newton-John Cancer Research Institute

OrgUnit's Researchers
(Persons)

Results 1-5 of 36 (Search time: 0.002 seconds).

FullnameTranslated NameEmail
Afshar-Sterle, ShoukatSkoukat.AFSHAR-STERLE@austin.org.au
Allan, Laura CLaura.Allan@onjcri.org.au
Anderson, Robin Lrobyn.anderson@austin.org.au
Ayati, Narjessnarjess.ayati@austin.org.au
Barraclough, AllisonAllison.BARRACLOUGH@austin.org.au

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Results 121-140 of 931 (Search time: 0.01 seconds).

Publication YearTitleAuthor(s)
121Jan-2022Can preclinical drug development help to predict adverse events in clinical trials?Chi, Lap Hing; Burrows, Allan D; Anderson, Robin L 
1222021Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells.Carli, Annalisa L E; Afshar-Sterle, Shoukat ; Rai, Alin; Fang, Haoyun; O'Keefe, Ryan; Tse, Janson; Ferguson, Fleur M; Gray, Nathanael S; Ernst, Matthias ; Greening, David W; Buchert, Michael
1237-Nov-2009Cancer stem cells in urologic cancers.Gedye, Craig; Davidson, Adee-Jonathan; Elmes, Martin R; Cebon, Jonathan S ; Bolton, Damien M ; Davis, Ian D
12426-Oct-2012A cancer vaccine induces expansion of NY-ESO-1-specific regulatory T cells in patients with advanced melanoma.Ebert, Lisa M; MacRaild, Sarah E; Zanker, Damien; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan
1251-Mar-2010Cancer vaccines: Where are we going?Cebon, Jonathan S 
12614-Jun-2022Cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma undergoing standard chemotherapy: a longitudinal feasibility study.Gates, Priscilla ; Krishnasamy, Meinir; Wilson, Carlene J ; Hawkes, Eliza A ; Doré, Vincent ; Perchyonok, Yuliya ; Rowe, Christopher C ; Walker, Adam K; Vardy, Janette L; de Ruiter, Michiel B; Cushion, Tania; Dhillon, Haryana M; Gough, Karla
1274-Nov-2010Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.Svobodová, Suzanne; Browning, Judy; MacGregor, Duncan; Pollara, Gabriele; Scolyer, Richard A; Murali, Rajmohan; Thompson, John F; Deb, Siddhartha; Azad, Arun A; Davis, Ian D; Cebon, Jonathan S 
12817-Feb-2009Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells.Gedye, Craig; Quirk, Juliet; Browning, Judy; Svobodová, Suzanne; John, Thomas ; Sluka, Pavel; Dunbar, P Rod; Corbeil, Denis; Cebon, Jonathan S ; Davis, Ian D
129Jan-2016Capture and on-chip analysis of melanoma cells using tunable surface shear forcesTsao, Simon Chang-Hao; Vaidyanathan, Ramanathan; Dey, Shuvashis; Carrascosa, Laura G; Christophi, Christopher ; Cebon, Jonathan S ; Shiddiky, Muhammad JA; Behren, Andreas; Trau, Matt
1301-Jan-1999Cardiac metastases from malignant melanoma.Gibbs, P; Cebon, Jonathan S ; Calafiore, Paul ; Robinson, W A
1315-Jan-2024Cardiometabolic Effects of Denosumab in Premenopausal Women with Breast Cancer Receiving Estradiol Suppression: RCT.Ramchand, Sabashini K ; Hoermann, Rudolf; White, Shane ; Yeo, Belinda ; Francis, Prudence A; Xu, Cecilia L H; Zajac, Jeffrey D ; Seeman, Ego ; Grossmann, Mathis 
1321-Jul-2019Cardiometabolic Effects of Endocrine Treatment of Estrogen Receptor-Positive Early Breast Cancer.Cheung, Yee-Ming Melody ; Ramchand, Sabashini K ; Yeo, Belinda ; Grossmann, Mathis 
13311-Aug-2023Cardiovascular Disease in Patients With Breast Cancer Treated in the Modern Era.Murphy, Alexandra C ; Koshy, Anoop N ; Farouque, Omar ; Yeo, Belinda ; Roccisano, Laura; Octavia, Yanti; Yudi, Matias B 
134Mar-2020A case of ANCA-associated vasculitis presenting de novo in pregnancy, successfully treated with rituximab.Pefanis, Aspasia; Williams, David S ; Skrzypek, H; Fung, A; Paizis, Kathy 
135Sep-2020Case of nivolumab-induced sclerosing cholangitis: lessons from long-term follow-up.McClure, Tess ; Cui, Wanyuan; Asadi, Khashayar ; John, Thomas ; Testro, Adam G 
13626-Oct-2020Caution in Expanding the Use of Abbreviated R-CHOP to Poor-Risk Limited-Stage DLBCL.Hawkes, Eliza A ; Opat, Stephen; Hertzberg, Mark
137Jan-2021CDK4/6 inhibitor plus endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: The new standard of care.Hui, Rina; de Boer, Richard; Lim, Elgene; Yeo, Belinda ; Lynch, Jodi
1382018Cell Line Models of Molecular Subtypes of Colorectal Cancer.Mooi, Jennifer K ; Luk, Ian Y; Mariadason, John M 
13931-Jul-2021Cell-Extrinsic Differentiation Block Mediated by EphA3 in Pre-Leukaemic Thymus Contributes to Disease Progression.Pliego Zamora, Adriana C; Ranasinghe, Hansini; Lisle, Jessica E; Ng, Chun Ki; Huang, Stephen; Wadlow, Racheal; Scott, Andrew M ; Boyd, Andrew W; Slape, Christopher I
1401-Dec-2015Cellular mechanisms underlying complete hematological response of chronic myeloid leukemia to BRAF and MEK1/2 inhibition in a patient with concomitant metastatic melanomaAndrews, Miles C; Turner, Natalie; Boyd, Janis; Roberts, Andrew W; Grigg, Andrew P ; Behren, Andreas; Cebon, Jonathan S